Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000034656 | SCV000243701 | likely benign | not provided | 2021-02-23 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22703879) |
Ambry Genetics | RCV000215282 | SCV000277729 | likely benign | Hereditary cancer-predisposing syndrome | 2021-07-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001081977 | SCV000544338 | benign | Tuberous sclerosis 2 | 2024-01-03 | criteria provided, single submitter | clinical testing | |
St. |
RCV001081977 | SCV000890931 | uncertain significance | Tuberous sclerosis 2 | 2023-05-31 | criteria provided, single submitter | clinical testing | The TSC2 c.4046C>T (p.Ala1349Val) missense change has a maximum subpopulation frequency of 0.011% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org). The in silico tool REVEL is inconclusive about a pathogenic or benign effect of this variant on protein function, and to our knowledge functional studies have not been performed. This variant has been reported in an individual with tuberous sclerosis complex who also harbored a second missense variant in TSC2 (LOVD database). The phase of these variants is unknown. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. |
Genome- |
RCV001081977 | SCV002039815 | likely benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000215282 | SCV002533492 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-10-12 | criteria provided, single submitter | curation | |
Biesecker Lab/Clinical Genomics Section, |
RCV000034656 | SCV000043539 | variant of unknown significance | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Uncertain significance. |